RESEARCH ARTICLE
Monocyte Chemotactic Protein-1 (MCP-1) as a Predictor of Prolonged Urinary Incontinence After Radical Prostatectomy
Michael A. Liss1, *, Thomas E. Ahlering2, Blanca Morales2, Adam Gordon2, Kathryn Osann3, Douglas Skarecky2, Achim Lusch2, Frank Zaldivar4, Gamal M. Ghoniem2
Article Information
Identifiers and Pagination:
Year: 2016Volume: 9
First Page: 44
Last Page: 50
Publisher ID: TOUNJ-9-44
DOI: 10.2174/1874303X01609010044
Article History:
Received Date: 8/8/2015Revision Received Date: 30/11/2015
Acceptance Date: 6/12/2015
Electronic publication date: 30/04/2016
Collection year: 2016

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
Objectives:
To investigate monocyte chemotactic protein-1 (MCP-1) as a novel urinary biomarker to predict prolonged post prostatectomy incontinence.
Methods:
Men submitted urine samples prior to robotic radical prostatectomy. MCP-1 values were derived using an ELISA test. Pad usage at 7, 30, and 60 days were documented by patient post cards mailed when zero pads was reached. The primary outcome was defined as no incontinence pad usage at 30 days at prostatectomy.
Results:
After exclusions, 76 patients were included in analyses. Continence was reached by 29% (22/76), 56% (42/76), and (75/76) 98% at 7, 30, and 60 days, respectively. The average MCP-1 (p=0.258) was not different between the continent and incontinent groups. Highest quartile of MCP-1 (MCP > 166 pg/mL) and normalized MCP-1 (MCP-1/TV >0.53) noted a significant delay in continence at 30 days (p=0.050 and p=0.003). Only 26% (5/19) in the highest MCP1/TV quartile were continent, whereas 65% (37/57) of men in the 3 lower quartiles reached zero pad continence (p=0.003). In a logistic regression model the highest quartile of MCP1/TV had a significant chance of being incontinent at 30 days (OR 0.22; 95% CI 0.058-0.80; p=0.022).
Conclusion:
MCP-1/TV is a urinary biomarker that may predict prolonged urinary incontinence after radical prostatectomy.